Voyager Therapeutics
VYGR
121 hedge funds and large institutions have $277M invested in Voyager Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 25 closing their positions.
2,056% more call options, than puts
Call options by funds: $194K | Put options by funds: $9K
32% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 37
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.73% less ownership
Funds ownership: 83.23% → 81.5% (-1.7%)
12% less funds holding
Funds holding: 138 → 121 (-17)
36% less capital invested
Capital invested by funds: $430M → $277M (-$153M)
64% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$7.02M |
| 2 |
Bank of New York Mellon
New York
|
+$3.91M |
| 3 |
BlackRock
New York
|
+$3.33M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.66M |
| 5 |
ClearBridge Investments
New York
|
+$2.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.29M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.39M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$3.6M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$3.21M |
| 5 |
Millennium Management
New York
|
-$3.1M |
VYGR Hedge Fund Activity: Q1 2020 in Review
121 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2020, worth a combined $277M — down 36% from $430M a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of VYGR and 9 opened new positions — a net loss of 16 holders — while 37 trimmed existing stakes and 49 added.
The largest buyer was Armistice Capital, adding an estimated $7.02M. The largest seller was Federated Hermes, cutting an estimated $6.29M.
- 121 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2020, down from 138 in Q4 2019.
- Funds reported $277M of Voyager Therapeutics stock for Q1 2020, down 36% quarter-over-quarter.
- 9 funds opened new Voyager Therapeutics positions in Q1 2020 and 25 closed out, a net change of -16 holders.
- The largest Voyager Therapeutics buyer in Q1 2020 was Armistice Capital, an estimated $7.02M added.
- The largest Voyager Therapeutics seller in Q1 2020 was Federated Hermes, an estimated $6.29M sold.
Based on aggregated 13F filings for Q1 2020.